Hampton, Va., March 25, 2025 /PRNewswire/ — Bioventra, the parent company and official manufacturer of Mitolyn, has announced a formal legal action against multiple third-party sellers accused of spreading misinformation and misleading consumers about their products. The asserting the growing issue of unauthorized sellers, false advertising, and misleading narratives across online marketplaces has prompted Mitolyn to address this challenge. As it continues to grow, Mitolyn has taken proactive steps to ensure transparency and credibility in its market.
Mitolyn has responded by initiating a cease-and-desist action against various third-party sellers identified as embezzling funds for other fraud schemes. The company emphasized that its products, available only through verified channels, are free from any form of fraud or counterfeit marketing. Mitolyn has dispatched cease-and-desist letters to multiple entities once identified under the ring sideshow, among other measures, stating that its legal response is part of their broader mission to protect consumers. Mitolyn has also released a statement outlining the activation of new production facilities and fulfillment centers across key distribution regions. These upgrades aim to reduce backorder wait times and prevent geographic stockouts, while also keeping the supply chain secure.
In parallel with the legal measures, Mitolyn has expanded its operations to meet the growing demand from verified markets. A team update outlined the new production facilities and fulfillment centers, highlighting their focus on reducing backorder wait times and ensuring stable replenishment cycles. Additionally, Mitolyn has confirmed an expansion of its supply chain by activating new facilities. By addressing the need for increased production capacity, the company aims to match the current demand, which surged significantly in February and March, prompting the company to fast-track its Q2 production roadmap. customers who are seeking verified product options can now access their selections more seamlessly.
Mitolyn has also invested in advanced technology to enhance quality control and ensure end users have a seamless purchasing experience. New verification systems, such as QR authentication codes, serialized packaging, and AI-monitored inspection checkpoints, are being rolled out across all violin products starting in April 2025. These systems will allow customers to quickly and reliably authenticate their products before use, ensuring that only legitimate sources are included. Mitolyn has also introduced an official Mitolyn authorized seller directory online, enabling buyers to cross-check any online or in-store seller and only proceed with purchases through verified channels. This move aims to strengthen the security of the supply chain and protect customers by ensuring only one legitimate seller is listed at a time.
Mitolyn customers who have noticed suspicious listings expressing concern have been directed to avoid further purchases and instead report the issue directly to the compliance team via the Mitolyn customer support center. Mitolyn has confirmed that additional legal proceedings, including antitrust investigations, may follow, contingent upon thorough oversight of the sales practices. The timeline for these proceedings and any necessary updates on enforcement, distributor changes, and security enhancements will be made available through official brand channels.
In summary, Mitolyn is actively working to address the growing issue of misinformation and ensure transparency. The company is committed to protecting consumers while maintaining secure and ethical purchasing experiences. With proactive steps in place, Mitolyn continues to establish itself as a trusted brand in the mitochondrial support industry. Students or interested individuals can learn more about Mitolyn, its products, and its commitment to quality and integrity.
